These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 30890230)
21. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991 [TBL] [Abstract][Full Text] [Related]
22. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431 [TBL] [Abstract][Full Text] [Related]
23. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221 [TBL] [Abstract][Full Text] [Related]
24. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization. Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710 [TBL] [Abstract][Full Text] [Related]
25. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
26. PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy. Byeon HJ; Kim I; Choi JS; Lee ES; Shin BS; Youn YS Int J Nanomedicine; 2015; 10():739-48. PubMed ID: 25632232 [TBL] [Abstract][Full Text] [Related]
27. A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy. Liu H; Gao M; Xu H; Guan X; Lv L; Deng S; Zhang C; Tian Y Pharm Res; 2016 Jan; 33(1):217-36. PubMed ID: 26334502 [TBL] [Abstract][Full Text] [Related]
28. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery. Xin Y; Liu T; Yang C Int J Nanomedicine; 2016; 11():5807-5821. PubMed ID: 27853366 [TBL] [Abstract][Full Text] [Related]
29. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness. Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700 [TBL] [Abstract][Full Text] [Related]
30. Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system. Guo L; Zhang H; Wang F; Liu P; Wang Y; Xia G; Liu R; Li X; Yin H; Jiang H; Chen B Int J Nanomedicine; 2015; 10():4535-47. PubMed ID: 26213467 [TBL] [Abstract][Full Text] [Related]
31. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles. Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975 [TBL] [Abstract][Full Text] [Related]
32. Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer. Sims LB; Curtis LT; Frieboes HB; Steinbach-Rankins JM J Nanobiotechnology; 2016 Apr; 14():33. PubMed ID: 27102372 [TBL] [Abstract][Full Text] [Related]
33. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery. Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060 [TBL] [Abstract][Full Text] [Related]
34. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging. Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150 [TBL] [Abstract][Full Text] [Related]
35. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Anti-Tumor Efficacy of Vorinostat Encapsulated Self-Assembled Polymeric Micelles in Solid Tumors. Rompicharla SVK; Trivedi P; Kumari P; Muddineti OS; Theegalapalli S; Ghosh B; Biswas S AAPS PharmSciTech; 2018 Oct; 19(7):3141-3151. PubMed ID: 30132129 [TBL] [Abstract][Full Text] [Related]
37. Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting. Park JH; Cho HJ; Kim DD Int J Nanomedicine; 2017; 12():7453-7467. PubMed ID: 29066894 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related]
39. Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue. Sims LB; Huss MK; Frieboes HB; Steinbach-Rankins JM J Nanobiotechnology; 2017 Oct; 15(1):67. PubMed ID: 28982361 [TBL] [Abstract][Full Text] [Related]